[Bio-matrix] International Speaker Line-up Announced for Pharma IQ's Next-Generation DNA Sequencing

Courtney Becker-James via biomatrx%40net.bio.net (by enquire from iqpc.co.uk)
Tue Nov 10 06:49:39 EST 2009


Dear Colleague,

Today's Next-Generation DNA Sequencing systems are opening novel fields and 
applications in biology studies and medical research. Beyond genomic 
sequencing, of which there are now many successful results, the technology is 
also allowing scientists to pursue:

- Personal genomics with detailed analysis of individual genome stretches
- Precise analysis of RNA transcripts for gene expression 
- Genome-wide characterisation and profiling of mRNAs, small RNAs and 
transcription factor regions
- Structure of chromatin and DNA methylation patterns
- Microbiology and metagenomics

At Pharma IQ's Next-Generation DNA Sequencing conference, January 18th - 20th 
in London, you will share study and technology pilot results with peers on how 
to utilise NGS systems to predict disease risk at genome level by using next-
generation systems to accurately scan and identify rare variants in genes, 
short sequence repeats and CNPs.

You will also discuss with other principal investigators how they're evaluating 
the right next generation approach for their research project, comparing deep 
vs. wide, de novo vs. re-sequencing and conventional microarray platforms. 

The international speaker panel includes:

-  Dr Nicholas H. Bergman, Principal Investigator and Genomics Team Leader, 
National Biodefense Analysis and Countermeasures Center
-  Dr Nick Loman, Head of Bioinformatics, University of Birmingham
-  Dr Daniel J. Turner, Head of Sequencing Technology Development, Wellcome 
Trust Sanger Institute
-  Dr Ina Vandenbroucke, Senior Scientist, Translational Genetics & Genomics, 
Tibotec - Virco BVBA
-  Dr Joris Veltman Department of Human Genetics, Radboud University Nijmegen 
Medical Centre
-  Dr Bhupinder Bhullar , Laboratory Head, Biomedical Research, Novartis
-  Dr Harma Feitsma, Research Scientist Molecular Diagnostics, Philips Research 
-  Dr Peter Verhasselt, Principal Scientist, Translational Genomics & Genetics, 
Johnson & Johnson Pharmaceutical Research & Development
-  Guy Cochrane, Team Leader, European Nucleotide Archive Team, European 
Bioinformatics Institute
-  Roderic Guigo, Senior Group Leader, Genomic Regulations, Biomedical 
Informatics, IMIM-Hospital del Mar
-  Bernd Timmermmann, Next Generation Sequencing Service Group, Max Planck 
Institute for Molecular Genetics

Don't miss this opportunity to hear from leading practitioners and technology 
users. Download the brochure for further information about the agenda:

NGS systems are rapidly evolving. However many challenges remain, including the 
development of robust protocols for generating sequencing libraries, building 
effective new approaches to data-analysis and often a rethinking of 
experimental design.

Sign up today for January's Next-Generation DNA Sequencing meeting to discuss 
how to overcome these challenges with other practitioners.

If you sign up before 20th November 2009, you can SAVE up to 400 GBP off the 
standard rates. Plus the first 10 academics to book on can take advantage of 
registering for only 399 GBP (+VAT)! For further information on the savings you 
could make, visit the website:

We look forward to meeting you in London in January.


Courtney Becker-James
Conference Director
Pharma IQ

PS: If you know who this meeting is most relevant for, please forward it to 
them so they have the opportunity to join their peers at this unique gathering!


This email was sent by:IQPC Ltd.

Anchor House 15-19 Britten Street, London, SW3 3QL, United Kingdom

Update Profile 


More information about the Biomatrx mailing list